Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The acquisition of CymaBay Therapeutics by Gilead Sciences in 2024 reshaped its strategic position
000 Market Concentration Fragmented market intensifies rivalry Top 5 vendors held ~60% share Product Differentiation Unique features reduce rivalry Advanced AI or specialized solutions
5 to ₹2 per kilometer
Servitization can increase revenue by 20-30% for manufacturers
expensive systems
KPLER PORTER'S FIVE FORCES TEMPLATE RESEARCH B_51 The acquisition of CymaBay TherapeuticsA Must Have Tool for Decision Makers Kpler faces intense competitive pressures from data rich incumbents and nimble startups, while customer bargaining and substitute analytics platforms shape pricing power and growth prospects. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Kpler's competitive dynamics, market pressures, and strategic advantages in detail. Suppliers Bargaining Power Dependence
US$ 3050.00
US$ 17500.00
US$ 40.00
US$ 654.50
US$ 200.00
US$ 6250.00
US$ 5500.00
US$ 2375.00
US$ 55.99
US$ 750.00
US$ 1500.00
